CCN2 and graft versus host disease: Post-hoc analysis revealed significant increased relative CTGF mRNA levels in BOS vs. controls (p=0.0020), GVHD vs. controls (p=0.0097), and trend towards higher CTGF mRNA content in RAS vs. controls (p=0.052).